PDS Biotech Announces Exercise of Warrants for $3.9M
NantWorks exercised outstanding warrants for approximately $3.9M in gross proceeds. Proceeds will support PDS0301 advancement and general corporate purposes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed